Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 126,19
Quantità: 1 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Da: PBShop.store US, Wood Dale, IL, U.S.A.
HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 125,20
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 148,28
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Springer, Springer Sep 2025, 2025
ISBN 10: 9819505194 ISBN 13: 9789819505197
Da: Rheinberg-Buch Andreas Meier eK, Bergisch Gladbach, Germania
EUR 149,79
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware -Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identified ranging from systemic to organ-specific diagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life. 292 pp. Englisch.
Lingua: Inglese
Editore: Springer, Springer Sep 2025, 2025
ISBN 10: 9819505194 ISBN 13: 9789819505197
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 149,79
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware -Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identified ranging from systemic to organ-specific diagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life. 292 pp. Englisch.
Lingua: Inglese
Editore: Springer, Springer Sep 2025, 2025
ISBN 10: 9819505194 ISBN 13: 9789819505197
Da: Wegmann1855, Zwiesel, Germania
EUR 149,79
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware -Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identifiedranging from systemic to organ-specificdiagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life.
Lingua: Inglese
Editore: Springer Verlag, Singapore, Singapore, 2025
ISBN 10: 9819505194 ISBN 13: 9789819505197
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identifiedranging from systemic to organ-specificdiagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Da: preigu, Osnabrück, Germania
EUR 126,15
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Cutting-Edge Strategies in Drug Delivery and Immunotherapy for Autoimmune Disorders | Young-Ok Son (u. a.) | Buch | viii | Englisch | 2025 | Springer | EAN 9789819505197 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Da: Revaluation Books, Exeter, Regno Unito
EUR 189,05
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 350 pages. 9.25x6.10x9.49 inches. In Stock.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: Springer, Springer Sep 2025, 2025
ISBN 10: 9819505194 ISBN 13: 9789819505197
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 151,59
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware - Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identified ranging from systemic to organ-specific diagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life.
Da: UK BOOKS STORE, London, LONDO, Regno Unito
EUR 228,46
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Da: Revaluation Books, Exeter, Regno Unito
EUR 226,10
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 350 pages. 9.25x6.10x9.49 inches. In Stock.
Lingua: Inglese
Editore: Springer, Springer Sep 2025, 2025
ISBN 10: 9819505194 ISBN 13: 9789819505197
Da: Books-by-Floh, Paderborn, Germania
EUR 190,60
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware -Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identifiedranging from systemic to organ-specificdiagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life. 292 pp. Englisch.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 118,26
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Springer, Springer Sep 2025, 2025
ISBN 10: 9819505194 ISBN 13: 9789819505197
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 149,79
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identifiedranging from systemic to organ-specificdiagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 292 pp. Englisch.
Da: Majestic Books, Hounslow, Regno Unito
EUR 221,49
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 218,23
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.